Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 362-370

  Rösl, Frank ^a   Das, Bhudev C ^a,b   Lengert, Maike ^a   Geletneky, Karsten ^a   Zur Hausen, Harald ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PYRROLIDINE DERIVATIVE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; ONCOGENE C FOS; PAPILLOMA VIRUS; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; UTERINE CERVIX CANCER; VIRUS TRANSCRIPTION;

EID: 0031060144     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.362-370.1997     Document Type: Article

References (87)

1. Abate, C., L. Patel, F. J. Rauscher III, and T. Curran. 1990. Redox regulation of Fos and Jun DNA-binding activity. Science 249:1157-1161.
2. Angel, P., E. A. Allegretto, S. T. Okino, K. Hattori, W. J. Boyle, T. Hunter, and M. Karin. 1988. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 10:166-171.
3. Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun proto-oncogene is positively autoregulated by its product, jun/AP-1. Cell 55:875-885.
4. Angel, P., and M. Karin. 1991. The role of jun, fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
5. Bohmann, D., T. J. Bos, A. Admon, T. Nishimura, P. K. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural functional properties of transcription factor AP-1. Science 238:1386-1392.
6. Boshart, M., L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, and H. zur Hausen. 1984. A new type of papillomavirus DNA and its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3:1151-1157.
7. Butz, K., and F. Hoppe-Seyler. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol. 67:6476-6486.
8. Butz, K., L. Shahabeddin, C. Geisen, D. Spitkovsky, A. Ullmann, and F. Hoppe-Seyler. 1995. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10:927-936.
9. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Choo, K.-B., C.-J. Huang, C.-M. Chen, C.-P. Han, and L.-C. Au. 1995. Jun-B oncogene aberrations in cervical cancer cell lines. Cancer Lett. 93:249-253.
11. Chui, R., P. Angel, and M. Karin. 1989. Jun-B differs in its biological properties from, and is a negative regulator of, c-jun. Cell 59:979-986.
12. Cripe, T. P., A. Alderborn, R. D. Anderson, S. Parkinen, P. Bergman, T. H. Haugen, U. Petterson, and L. P. Turek. 1990. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. New Biol. 2:450-463.
13. Dani, C., J. M. Blanchard, M. Piechaczyk, S. El-Sabouty, L. Marty, and P. Jeanteur. 1984. Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA 81:7046-7050.
14. Desaintes, C., S. Hallez, P. van Alphen, and A. Burny. 1992. Transcriptional activation of several heterologous promoters by E6 protein of human papillomavirus type 16. J. Virol. 66:325-333.
15. Desaintes, C., S. Hallez, O. Detremmerie, and A. Burny. 1995. Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoter through the epithelial specific enhancer. Oncogene 10:2155-2161.
16. deWet, J. R., K. V. Wood, M. Deluca, D. R. Helinski, and S. Subramani. 1987. Firely luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725-737.
17. Dignam, J. D., R. M. Lebowitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated nuclei. Nucleic Acids Res. 11:1475-1489.
18. Dürst, M., L. Gissmann, H. Ikenberg, and H. zur Hausen. 1983. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA 80:3812-3815.
19. Dürst, M., R. T. Petrussevska, P. Boukamp, N. E. Fusenig, and L. Gissmann. 1987. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus 16 DNA. Oncogene 1:251-256.
20. Dyson, N., P. M. Howley, K. Münger, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
21. East, C. J., C. N. Abboud, and R. F. Borch. 1992. Diethyldithiocarbamate induction of cytokine release in human long-term bone marrow cultures. Blood 80:1172-1177.
22. El-Deiry, W., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
23. Feinberg, A., and B. A. Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267.
24. Frank, N., A. Christmann, and E. Frei. 1995. Comparative studies on the pharmacokinetics of hydrophilic prolinedithiocarbamate, sarcosinedithiocarbamate and the less hydrophilic diethyldithiocarbamate. Toxicology 95:113-122.
25. Fujii, M., T. Niki, T. Mori, T. Matsuda, M. Matsui, N. Nomura, and M. Seiki. 1991. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 6:1023-1029.
26. Goossens, V., J. Grooten, K. deVos, and W. Fiers. 1995. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA 92:8115-8119.
27. Gorman, C. M., L. F. Moffat, and B. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1490-1493.
28. Gunning, P., P. Ponte, H. Okayama, J. Engel, H. Blau, and L. Kedes. 1983. Isolation and characterization of full-length cDNA clones for human α-, β-, and γ-actin mRNAs; skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol. 3:787-795.
29. Hainaut, P., and J. Milner. 1993. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53:4469-4473.
30. Holmgren, A. 1985. Thioredoxin. Annu. Rev. Biochem. 54:237-271.
31. Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375-387.
32. Jesudasan, R. A., R. A. Rahman, S. Chandrashekharappa, G. A. Evans, and E. Srivatsan. 1995. Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am. J. Hum. Genet. 56:705-715.
33. Khandjian, E. W., and C. Meric. 1986. A procedure for Northern blot analysis of native RNA. Anal. Biochem. 159:227-232.
34. Koi, M., H. Morita, H. Yamada, H. Satoh, J. K. Barrett, and M. Oshimura. 1989. Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol. Carcinog. 2:12-21.
35. Kunze, N., M. Klein, A. Richter, and R. Knippers. 1990. Structural characterization of the human DNA topoisomerase I gene promoter. Eur. J. Biochem. 194:323-330.
36. Kyo, S., A. Tam, and L. A. Laimins. 1995. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP-1 with two novel cellular factors. Virology 211:184-197.
37. Lechner, M. S., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045-3052.
38. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
39. Linial, M., N. Gunderson, and M. Groudine. 1985. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science 230:1126-1132.
40. Los, M., W. Dröge, K. Stricker, P. A. Baeuerle, and K. Schulze-Osthoff. 1995. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25:159-165.
41. Lukow, B., and G. Schütz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
42. Matsuda, M., H. Matsutani, H. Nakamura, S. Miyajima, A. Yamauchi, S. Yonehara, A. Uchida, K. Irimajiri, A. Horiuchi, and J. Yodoi. 1991. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147:3837-3841.
43. Mattews, J. R., N. Wakasugi, J. L. Virelizier, J. Yodoi, and R. T. Hay. 1992. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 15:3821-3830.
44. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells; AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:2005-2015.
45. Müller, R., J. M. Tremblay, E. D. Adamson, and I. M. Verma. 1983. Tissue and cell type-specific expression of two human c-onc genes. Nature 304:454-456.
46. Münger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4423.
47. Nakabeppu, Y., K. Ryder, and D. Nathans. 1988. DNA binding activities of three murine jun proteins: stimulation by fos. Cell 55:907-915.
48. Oberley, T. D., J. L. Schultz, N. Li, and L. W. Oberley. 1995. Antioxidant enzyme levels as a function of growth state in cell culture. Free Radical Biol. Med. 19:53-65.
49. Offord, E. A., and P. Beard. 1990. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J. Virol. 64:4792-4798.
50. Papavassiliou, A. G., M. Treier, C. Chavrier, and D. Bohmann. 1992. Targeted degradation of c-fos, but not v-fos, by a phosphorylation-dependent signal on c-jun. Science 258:1941-1944.
51. Papavassiliou, G. A., M. Treier, and D. Bohmann. 1995. Intramolecular signal transduction in c-jun. EMBO J. 14:2014-2019.
52. Phelps, W. C., C. L. Yee, K. Münger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1a. Cell 53:539-547.
53. Polack, A., D. Eick, E. Koch, and G. W. Bornkamm. 1987. Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells. EMBO J. 6:2959-2964.
54. Rainwater, R., D. Parks, M. E. Anderson, P. Tegtmeyer, and K. Mann. 1995. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 15:3892-3903.
55. Rösl, F., M. Dürst, and H. zur Hausen. 1988. Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine. EMBO J. 7:1321-1328.
56. Rösl, F., T. Achtstätter, T. Bauknecht, G. Futterman, K. J. Hutter, and H. zur Hausen. 1991. Extinction of the HPV 18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective condition. EMBO J. 10:1337-1345.
57. Rösl, F., M. Lengert, J. Albrecht, K. Kleine, R. Zawatzky, B. Schraven, and H. zur Hausen. 1994. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J. Virol. 68:2142-2150.
58. 57a. Rösl, F., and H. zur Hausen. Unpublished data.
59. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
60. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
61. Sato, K., H. Taguchi, T. Maeda, H. Minami, Y. Asada, Y. Watanabe, and K. Yoshikawa. 1995. The primary cytotoxicity in ultraviolet A irradiated riboflavin solution is derived from hydrogen peroxide. J. Invest. Dermatol. 105:608-612.
62. Saxon, P. J., E. S. Srivatsan, and E. J. Stanbridge. 1986. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J. 5:3461-3466.
63. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
64. Scheidereit, C., J. A. Cromlish, T. Gerster, K. Kawakami, C. Balmaceda, R. A. Currie, and R. G. Roeder. 1988. A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homeobox protein. Nature 336:551-557.
65. Schenk, H., M. Klein, W. Erdbrügger, W. Dröge, and K. Schulze-Osthoff. 1994. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA 91:1672-1676.
66. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcriptions factor and HIV-1. EMBO J. 10:2247-2258.
67. Schreck, R., R. Grassmann, B. Fleckenstein, and P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type 1 tax protein. J. Virol. 66:6288-6293.
68. Schreck, R., B. Meier, D. N. Männel, W. Dröge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor B activation in intact cells. J. Exp. Med. 175:1181-1194.
69. Schulze-Osthoff, K., and P. A. Baeuerle. 1995. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem. Pharmacol. 50:735-741.
70. Schütte, J., J. Viallet, M. Nau, S. Segal, J. Fedorko, and J. Minna. 1989. jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59:987-997.
71. Shyy, J. Y., M. C. Lin, J. Han, Y. Lu, M. Petrime, and S. Chien. 1995. The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemoattractant protein 1 gene expression. Proc. Natl. Acad. Sci. USA 92:8069-8073.
72. Sinke, R. J., A. Tanigami, Y. Nakamura, and A. Geruts van Kessel. 1993. Reverse mapping of the gene encoding the human fos-related antigen-1 (fra-1) within chromosome band 11q13. Genomics 18:165.
73. Srivatsan, E. S., B. C. Misra, M. Venugopalan, and S. P. Wilczynski. 1991. Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am. J. Hum. Genet. 49:868-877.
74. Stanbridge, E. J., C. J. Der, C.-J. Doersen, R. Y. Nishimi, D. M. Peehl, B. E. Weissman, and J. E. Wilkinson. 1982. Human cell hybrids: analysis of transformation and tumorigenicity. Science 215:252-259.
75. Stein, B., H. J. Rahmsdorf, A. Steffen, M. Litfin, and P. Herrlich. 1989. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol. Cell. Biol. 9:5169-5181.
76. Suzuki, T., H. Okuno, T. Yoshida, T. Endo, H. Nishina, and H. Iba. 1991. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19:5537-5542.
77. Takimoto, M., J. P. Quinn, A. R. Farina, L. M. Staudt, and D. Levens. 1989. fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. J. Biol. Chem. 264:8992-8999.
78. Thierry, F., G. Spyrou, M. Yaniv, and P. M. Howley. 1992. Two AP-1 sites binding jun B are essential for human papillomavirus type 18 transcription in keratinocytes. J. Virol. 66:3740-3748.
79. Toledano, M. B., and W. J. Leonard. 1991. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88:4328-4332.
80. Tsurumi, C., N. Ishida, T. Tamura, A. Kakizuka, E. Nishida, E. Okumura, T. Kishimoto, M. Inagaki, K. Okazaki, N. Sagata, A. Ichihara, and K. Tanaka. 1995. Degradation of c-fos by the 26S proteasome is accelerated by c-jun and multiple protein kinases. Mol. Cell. Biol. 15:5682-5687.
81. Ueda, A., K. Okuda, S. Ohno, A. Shirai, T. Igarashi, K. Matsunaga, J. Fukushima, Y. Kawamoto, and T. Okubo. 1994. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153:2052-2063.
82. Wakasugi, N., Y. Tagaya, H. Wakasugi, A. Mitsui, M. Maeda, J. Yodoi, and T. Tursz. 1990. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc. Natl. Acad. Sci. USA 87:8282-8286.
83. Werness, B. A., A. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
84. Yoshioka, K., T. Deng, M. Cavigelli, and M. Karin. 1995. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc. Natl. Acad. Sci. USA 92:4972-4976.
85. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
86. zur Hausen, H. 1994. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 343:955-957.
87. zur Hausen, H., and A. Schneider. 1987. The role of papillomavirus in human anogenital cancer, p. 245-263. In N. P. Salzman, and P. M. Howley (ed.), The Papovaviridae, vol. 2. Plenum Press, New York, N.Y.